PubMed · 2006 · 99 citations · 16 references
MedicineNuclear MedicineOncologyBiomedical ImagingMolecular ImagingMolecular OncologyPositron Emission TomographyProstate Cancer ImagingProstate ImagingTumor ImagingTumor Receptor ImagingConcentrationCopper Accumulation In TissuesCopper Transporter 1 (Ctr1)Copper TransportersDiagnostic ImmunohistochemistryImmunohistochemistry Assays
UNLABELLED: Our objective was to determine whether human prostate cancer xenografts in mice can be localized by PET using 64CuCl2 as a probe (64Cu PET). METHODS: Athymic mice bearing human prostate cancer xenografts were subjected to 64Cu PET, followed by quantitative analysis of the tracer concentrations and immunohistochemistry study of human copper transporter 1 expression in the tumor tissues. RESULTS: Human prostate cancer xenografts expressing high levels of human copper transporter 1 were well visualized on the PET images obtained 24 h after injection but not on the images obtained 1 h after injection. PET quantitative analysis demonstrated a high concentration of 64CuCl2 in the tumors in comparison to that in the left shoulder regions (percentage injected dose per gram of tissue: 3.6 +/- 1.3 and 0.6 +/- 0.3, respectively; P = 0.004), at 24 h after injection. CONCLUSION: The data from this study suggested that locally recurrent prostate cancer might be localized with 64Cu PET using 64CuCl2 as a probe.
16
PET imaging of prostate cancer using carbon-11-choline.
Toshihiko Hara, N Kosaka, Hirofumi Kishi · PubMed · 1998 · 520 citations